Efficacy and Safety of Proton Pump Inhibitors (PPIs) Plus Rebamipide for Endoscopic Submucosal Dissection-induced Ulcers: A Meta-analysis

Abstract

Objective To compare the efficacy of proton pump inhibitors (PPIs) with rebamipide versus PPIs alone for the treatment of ulcers after endoscopic submucosal dissection (ESD). Methods PubMed, Web of Science, Medline, Embase, the Cochrane Central Register of Controlled Trials and China Naitonal Knowledge Infrastructure were searched up to the end of October 2013 in order to identify all randomized controlled trials reporting the effects of PPIs plus rebamipide on healing ulcers after ESD. The outcome measurement was complete ulcer healing. Results A total of six studies involving 724 patients were included. The pooled data suggested a significantly higher rate of ulcer healing after endoscopic therapy among patients treated with PPIs plus rebamipide than among those treated with PPIs alone [odds ratio (OR)=2.40, 95% confidence interval (CI): 1.68-3.44]. The subgroup analysis showed PPI plus rebamipide therapy to be more effective in healing ESD-induced ulcers than treatment with PPIs alone after both four (OR=2.22, 95%CI: 1.53-3.24) and eight weeks of treatment (OR=3.19, 95%CI: 1.22-8.31). In addition, the combination therapy was found to be significantly more effective than the use of PPIs alone for all ESD ulcers greater than 20 mm in size (OR=4.77, 95%CI: 2.22-10.26). There were no significant differences between the treatment groups with regard to ulcer location (low, middle or upper stomach) or the presence of absence of H. pylori infection. No serious adverse events were observed in either group. Conclusion The results of this meta-analysis suggest that treatment with PPIs plus rebamipide is superior to PPI monotherapy for healing ESD-induced ulcers over four weeks, particularly large ulcers. However, more well-designed trials are needed to confirm these findings.

Risk factors for bleeding after gastric endoscopic submucosal dissection: a systematic review and meta-analysis

“…Indeed, although mucoprotectives were associated with faster healing of the artificial ulcer in 2 recent reviews, 87,88 its impact on PPB was not evaluated, and so it remains unclear if these faster healing decreases PPB.…”

Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trial

“…H. pylori plays an important pathogenic role in peptic ulcers, and eradication accelerates peptic ulcer healing and reduces ulcer recurrence . Several reports have shown that the infection status of H. pylori does not affect ulcer healing after ESD . However, in a prospective randomized study, Cheon et al.…”

Efficacy of hemostatic powder in preventing bleeding after gastric endoscopic submucosal dissection in high‐risk patients

“…There were previous reports trying to close the mucosal defect with an overstitch endoscopic suturing device or detachable snare and clips immediately after ESD. Several studies showed that combination of PPI and rebamipide, a free radical scavenger, promoted artificial ulcer healing after ESD . However, closing methods or gastric mucosa protective agents combination therapy could not show significant reduction in the rate of post‐ESD bleeding.…”